Böhmig M - Search Results

1

Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma.

Ding WQ, Kuntz S, Böhmig M, Wiedenmann B, Miller LJ. Ding WQ, et al. Among authors: bohmig m. Gastroenterology. 2002 Feb;122(2):500-11. doi: 10.1053/gast.2002.31039. Gastroenterology. 2002. PMID: 11832464

2

Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography.

Lopez Hänninen E, Amthauer H, Hosten N, Ricke J, Böhmig M, Langrehr J, Hintze R, Neuhaus P, Wiedenmann B, Rosewicz S, Felix R. Lopez Hänninen E, et al. Among authors: bohmig m. Radiology. 2002 Jul;224(1):34-41. doi: 10.1148/radiol.2241010798. Radiology. 2002. PMID: 12091659 Clinical Trial.

3

[Diagnosis and staging of pancreatic carcinomas].

Böhmig M, Wiedenmann B, Rosewicz S. Böhmig M, et al. Dtsch Med Wochenschr. 2001 Feb 2;126(5):113-6. doi: 10.1055/s-2001-10863. Dtsch Med Wochenschr. 2001. PMID: 11225386 Review. German. No abstract available.

4

Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center.

Pape UF, Böhmig M, Berndt U, Tiling N, Wiedenmann B, Plöckinger U. Pape UF, et al. Among authors: bohmig m. Ann N Y Acad Sci. 2004 Apr;1014:222-33. doi: 10.1196/annals.1294.025. Ann N Y Acad Sci. 2004. PMID: 15153439

5

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

Pape UF, Berndt U, Müller-Nordhorn J, Böhmig M, Roll S, Koch M, Willich SN, Wiedenmann B. Pape UF, et al. Among authors: bohmig m. Endocr Relat Cancer. 2008 Dec;15(4):1083-97. doi: 10.1677/ERC-08-0017. Epub 2008 Jul 4. Endocr Relat Cancer. 2008. PMID: 18603570

6

[Therapy of pancreatic adenocarcinoma].

Böhmig M, Wiedenmann B, Rosewicz S. Böhmig M, et al. Med Klin (Munich). 1999 Nov 15;94(11):614-25. doi: 10.1007/BF03045002. Med Klin (Munich). 1999. PMID: 10603733 Review. German.

7

Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours.

Hessenius C, Bäder M, Meinhold H, Böhmig M, Faiss S, Reubi JC, Wiedenmann B. Hessenius C, et al. Among authors: bohmig m. Eur J Nucl Med. 2000 Nov;27(11):1684-93. doi: 10.1007/s002590000325. Eur J Nucl Med. 2000. PMID: 11105825

8

Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer.

Schulz P, Fischer C, Detjen KM, Rieke S, Hilfenhaus G, von Marschall Z, Böhmig M, Koch I, Kehrberger J, Hauff P, Thierauch KH, Alves F, Wiedenmann B, Scholz A. Schulz P, et al. Among authors: bohmig m. FASEB J. 2011 Oct;25(10):3325-35. doi: 10.1096/fj.11-182287. Epub 2011 Jun 17. FASEB J. 2011. PMID: 21685330

9

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.

Faiss S, Pape UF, Böhmig M, Dörffel Y, Mansmann U, Golder W, Riecken EO, Wiedenmann B; International Lanreotide and Interferon Alfa Study Group. Faiss S, et al. Among authors: bohmig m. J Clin Oncol. 2003 Jul 15;21(14):2689-96. doi: 10.1200/JCO.2003.12.142. J Clin Oncol. 2003. PMID: 12860945 Clinical Trial.

10

Combined imaging techniques for pancreatic cancer.

Hosten N, Lemke AJ, Wiedenmann B, Böhmig M, Rosewicz S. Hosten N, et al. Among authors: bohmig m. Lancet. 2000 Sep 9;356(9233):909-10. doi: 10.1016/s0140-6736(00)02683-0. Lancet. 2000. PMID: 11036898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters